17pL3.3 and 17q21, which refect inactivation of tumoursuppressor genes in these chromosomal regions, have been found in this type of cancer (Callahan and Campbell, 1989; Sato et al., 1990 Sato et al., , 1991 Cornelis et al., 1993) . On the other hand, it is known that oestrogen and other steroid hormones play a signifiant role in the aetiology of breast cancer on the basis of results from epidemiological, clinical and in vitro studies (Wittlife, 1984; Henderson et al., 1988; Thompson et al., 1990; Beck and Edwards, 1991; Martin, 1991) . Oestrogen is the primary hormonal stimulant for proliferation of breast epithelial cells; proliferatng cells appear to sustain a higher risk of undergoing genetic alterations and malignant transformation.
Breast cancers in early stages generally maintain oestrogendependent growth. During their progression, however, some lose hormonal control. Their status in this respect, i.e. the hormone dependency or independency of the breast tumour, can be monitored by measurement of oestrogen/progesterone receptors (Wittlife, 1984; Beck and Edwards, 1991; Martin, 1991; Horwitz, 1993 September 1989 to December 1993, all 616 patients from whom tumours and their corresponding non-cancerous tissues were available were included in the present study; part of this study has also been described previously (Sato et al., 1990 (Sato et al., , 1991 (Feinberg and Vogelstein, 1984) . Prehybridisation, hybridisation and autoradiography were carried out as described elsewhere (Sato et al., 1990) . The membranes were stripped in 0.4 N sodium hydroxide and repeatedly hybnrdised.
Definition of LOH and amplification LOH and amplification were assessed by quantification of the signal intensities or allelic dosage of the polymorphic alleles be means of a Hoefer GS-300 scanning densitometer as previously descnibed (Fujiwara et al., 1993 Figure 1 . Table II (Horwitz, 1993) . Since LOH at 17q21, LOH at 17pl3.3 and amplification of ERBB2 was strongly associated with the loss of hormone receptors and possibly in subsequent hormonal deregulation, these three genetic alterations might be reflecting a specific aspect of the molecular biology of malignancy in breast cancer. As such, they may prove useful in predicting prognosis and responsiveness to hormonal therapy when used in conjunction with tests for hormone receptor status.
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